Preferential use of B7.2 and not B7.1 in priming of vaccinia virus-specific CD8 T cells. - Wikidata - awgldk - TriplyDB

Preferential use of B7.2 and not B7.1 in priming of vaccinia virus-specific CD8 T cells.

Preferential use of B7.2 and not B7.1 in priming of vaccinia virus-specific CD8 T cells.

http://www.wikidata.org/entity/Q37255184

about

CD8 T cells use IFN-γ to protect against the lethal effects of a respiratory poxvirus infection.The TNFR family members OX40 and CD27 link viral virulence to protective T cell vaccines in mice Differential requirements for CD80/86-CD28 costimulation in primary and memory CD4 T cell responses to vaccinia virus.Immunodomination during peripheral vaccinia virus infection.B cell-specific expression of B7-2 is required for follicular Th cell function in response to vaccinia virus.CD4+ T cell help is dispensable for protective CD8+ T cell memory against mousepox virus following vaccinia virus immunization.CD8 T cell memory to a viral pathogen requires trans cosignaling between HVEM and BTLA.T cell receptor signaling can directly enhance the avidity of CD28 ligand binding.Targeting OX40 promotes lung-resident memory CD8 T cell populations that protect against respiratory poxvirus infection Ubiquitin-mediated regulation of CD86 protein expression by the ubiquitin ligase membrane-associated RING-CH-1 (MARCH1).Multiple layers of CD80/86-dependent costimulatory activity regulate primary, memory, and secondary lymphocytic choriomeningitis virus-specific T cell immunity Transient IL-10 receptor blockade can enhance CD8(+) T cell responses to a simian adenovirus-vectored HIV-1 conserved region immunogen CD8 T cells are essential for recovery from a respiratory vaccinia virus infection.Natural Killer Cells and Innate Interferon Gamma Participate in the Host Defense against Respiratory Vaccinia Virus Infection.Anatomically restricted synergistic antiviral activities of innate and adaptive immune cells in the skin.Viral Persistence Induces Antibody Inflation without Altering Antibody Avidity Tumor necrosis factor receptor/tumor necrosis factor family members in antiviral CD8 T-cell immunity.OX40:OX40L axis: emerging targets for improving poxvirus-based CD8(+) T-cell vaccines against respiratory viruses CD8+ T Cells Orchestrate pDC-XCR1+ Dendritic Cell Spatial and Functional Cooperativity to Optimize Priming.HVEM Imprints Memory Potential on Effector CD8 T Cells Required for Protective Mucosal Immunity.Inflammatory monocytes contribute to the persistence of CXCR3hi CX3CR1lo circulating and lung-resident memory CD8+ T cells following respiratory virus infection.

P2860

Q33677183-8B2B7E38-B5FE-4F4F-ADAA-250E7B469131 Q34428899-C5923061-A4E6-44D3-9539-E5828BAEC8CA Q34644837-735E6688-612D-4022-BF5D-807E8EB8BEFF Q34697921-CF3A505A-9631-4C24-9EA8-E40CB309F5BA Q34950531-8F63F611-3EAE-4622-8E13-5AD8CDB1696E Q34992708-680AD1F5-023E-4F3A-AB99-3512DDA340D4 Q35035884-BCCD57E2-8A91-467C-9224-773B36695A65 Q35106950-04F47685-2209-4E7C-AF02-7B42A3272540 Q35193006-157CCB3B-F328-4CB6-9237-651465ADBF2D Q35423428-ECD591F0-38CF-41CE-A912-7DBE55000D69 Q35826538-BA563B58-2D2D-41A1-B9B6-0FFA54C66E47 Q35887443-22F5B5DA-DF52-4C2D-A8F4-C86EBA94BD95 Q36394928-DB02EB45-EE9D-4012-8DFD-5B4CC7D90BFD Q36433932-EE6FFB7F-C0BD-492A-A0AE-3B2326C966CA Q36665882-4FDDE3B6-138F-48CB-A9D1-EF8F6AB37971 Q36811912-6E627215-B554-4327-962C-14DE98320329 Q37727208-64B6ADF5-63F4-4EFE-881F-0DA9C1D15494 Q37948126-CA9E3ADC-B4A0-4227-8165-20B749AC05BB Q38964925-3DE214BD-776C-4C71-8DC9-E4B7D6A24ACC Q40060920-0DC203B6-B9C9-4369-85E8-246061A54290 Q47549472-35C3ABA1-4F2B-4051-B043-F82E65F607AF

P2860

Preferential use of B7.2 and not B7.1 in priming of vaccinia virus-specific CD8 T cells.

http://www.wikidata.org/entity/Q37255184

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Preferential use of B7.2 and not B7.1 in priming of vaccinia virus-specific CD8 T cells.

@en

Preferential use of B7.2 and not B7.1 in priming of vaccinia virus-specific CD8 T cells.

@nl

type

label

Preferential use of B7.2 and not B7.1 in priming of vaccinia virus-specific CD8 T cells.

@en

Preferential use of B7.2 and not B7.1 in priming of vaccinia virus-specific CD8 T cells.

@nl

prefLabel

Preferential use of B7.2 and not B7.1 in priming of vaccinia virus-specific CD8 T cells.

@en

Preferential use of B7.2 and not B7.1 in priming of vaccinia virus-specific CD8 T cells.

@nl

P1433

Q37255184-3B41AF85-1F6F-4CFC-B879-D1FC7D7B00CA

P1476

Q37255184-5B0A0906-EBCB-4BCA-BCFE-B147E41E1013

P2093

Q37255184-1C03D44E-A082-4978-BB1E-4B39C11BC28F

Q37255184-30E0A67E-3AF2-451B-81F9-6393067FDF63

Q37255184-6D4275AB-48FE-4FB8-8BCD-7600E60664FB

Q37255184-BEA4E309-D9FA-4A22-B803-F2563B6A8FAA

P2860

Q37255184-0089FC60-7638-4FD1-B150-738886DB9B19

Q37255184-01437937-9B5A-45AE-B004-736ACE07288B

Q37255184-03FB1ACE-90AC-45BD-A979-73DDEFBBE6BD

Q37255184-049C9DA4-D396-4690-B491-061FD76BF5C5

Q37255184-09D6DBC0-70E0-4B09-9E66-A37F3199221A

Q37255184-0CE15E86-9B9B-4DD4-AEA7-05EA7338D2D3

Q37255184-0CFAD77D-6E3D-4861-A5DF-9C17A62C6B66

Q37255184-1432BDEE-4F8B-4C3B-AC43-85B8CE94D1D3

Q37255184-155F77C2-0CA1-4D37-AF7B-9AAFEB6F6EFD

Q37255184-213DD3F2-4D73-4B08-B106-A0D0B4F08287

P304

Q37255184-2FE3B1E4-0F20-4370-AAE9-51A85B7310E5

P31

Q37255184-0C162C8D-CB26-46D2-98BA-090319A3E570

P356

Q37255184-F047BA78-F96A-4F7D-B5CA-8FD9D80C45BE

P407

Q37255184-57C96874-147C-43A5-A68A-9AE67523CEF9

P433

Q37255184-61EAF69F-3416-4EF1-9260-B4B60D488283

P478

Q37255184-7BD03895-7D5D-4887-8AF7-619108F0266B

P50

Q37255184-73EFAEAF-E41D-4272-ACB9-84D33D5FEEAE

Q37255184-d42a75f1-48fd-a61c-808d-16bc519cdde0

P577

Q37255184-EB6A625D-71BC-448E-B666-7538A098135C

P5875

Q37255184-FF7296DD-662A-4040-BF73-EF60EF230E91

P698

Q37255184-19516381-3E4A-4713-8A46-5472B037BFD2

P932

Q37255184-EF685C00-DC68-47EE-AB55-8C07B5AF6480

P356

JIMMUNOL.0803545

P1433

Journal of Immunology

P1476

Preferential use of B7.2 and not B7.1 in priming of vaccinia virus-specific CD8 T cells.

@en

P2093

Michael Croft

http://www.w3.org/2001/XMLSchema#string

Rachel Flynn

http://www.w3.org/2001/XMLSchema#string

Ramon Arens

http://www.w3.org/2001/XMLSchema#string

Shahram Salek-Ardakani

http://www.w3.org/2001/XMLSchema#string

P2860

Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?

The B7 family revisited

CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL

Identification of a mouse cytomegalovirus gene selectively targeting CD86 expression on antigen-presenting cells.

Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines

Role of CD28/CD80-86 and CD40/CD154 costimulatory interactions in host defense to primary herpes simplex virus infection.

Human immunodeficiency virus type 1 Vpr impairs dendritic cell maturation and T-cell activation: implications for viral immune escape.

Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice.

Control of memory CD8+ T cell differentiation by CD80/CD86-CD28 costimulation and restoration by IL-2 during the recall response.

CD28(-/-) mice show defects in cellular and humoral immunity but are able to control infection with murine gammaherpesvirus 68.

P304

2909-2918

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.0803545

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

182

http://www.w3.org/2001/XMLSchema#string

P50

Alessandro Sette

Stephen Schoenberger

P577

2009-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24031991

http://www.w3.org/2001/XMLSchema#string

P698

19234186

http://www.w3.org/2001/XMLSchema#string

P932

2707928

http://www.w3.org/2001/XMLSchema#string